155 results
144
ZNTL
Zentalis Pharmaceuticals Inc
31 May 24
Notice of proposed sale of securities
6:28pm
The sale reported in this Form 144 was to satisfy withholding tax obligations upon the vesting
144
ZNTL
Zentalis Pharmaceuticals Inc
9 May 24
Notice of proposed sale of securities
7:47pm
>
Y
The sale reported in this Form 144 was to satisfy withholding tax
8-K
EX-99.1
ZNTL
Zentalis Pharmaceuticals Inc
7 May 24
Zentalis Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational Progress
7:03am
) before income taxes
Income tax expense
Loss on equity method investment
Net income (loss)
Net loss attributable to noncontrolling interests
Net
S-3ASR
EX-4.3
2w9pbhvda
29 Feb 24
Automatic shelf registration
5:14pm
S-3ASR
EX-1.2
7vkb29h1yv
29 Feb 24
Automatic shelf registration
5:14pm
S-3ASR
lr2ds
29 Feb 24
Automatic shelf registration
5:14pm
8-K
EX-99.1
s8hbli9wf
27 Feb 24
Zentalis Pharmaceuticals Reports Full Year 2023 Financial Results and Operational Updates
7:04am
144
bjt6jj482mek
12 Feb 24
Notice of proposed sale of securities
8:25pm
144
qgilol2dhc6bz
12 Feb 24
Notice of proposed sale of securities
8:25pm
144
lz6zmhclhu2
12 Feb 24
Notice of proposed sale of securities
8:23pm